News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ImmunoCellular Therapeutics, Ltd Announces First Quarter 2013 Financial Results



5/10/2013 7:35:20 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced financial results for the quarter ended March 31, 2013.

For the quarter ended March 31, 2013, the Company incurred a net loss of $5.0 million, or $0.10 per basic and diluted share compared to a net loss of $7.9 million for the quarter ended March 31, 2012, or $0.21 per basic and diluted share.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES